English
Specials
    Upgrade
    MoneycontrolBe a PRO
    Moneycontrol PRO

    business

    Sun Pharma Q3 profit seen up 27%; US & India biz may grow 10%

    According to average of estimates of analysts polled by CNBC-TV18, revenue during the quarter may increase 11.6 percent year-on-year to Rs 7,905.3 crore, driven by Sun's authorised generic (AG) launches of Daichi Sankyo drugs in US.

    first published: Feb 13, 2017 05:47 pm

    LATEST VIDEOS

    Watch More →

    A collection of the most-viewed Moneycontrol videos.

    Watch and Follow our leading shows